Medicare Enrolled
Dr. Yamil Kouri, M.D.
Hematology & Oncology · Lakewood Ranch, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kouri from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kouri?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kouri
Dr. Yamil Kouri is a hematology & oncology specialist in Lakewood Ranch, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kouri performed 25,514 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Kouri received a total of $19,940 from 68 pharmaceutical and/or device companies across 408 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kouri is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 21% volume in FL
$19,940 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 158230 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗25,514
Medicare services
Top 21% in FL for hematology & oncology
Not available
Unique patients (not deduplicated)
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
14,250 | $1 | $2 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
3,200 | $6 | $15 |
| Denosumab injection (Prolia/Xgeva) | 2,880 | $17 | $43 |
| Iron infusion (Monoferric) | 1,400 | $16 | $42 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
842 | $8 | $16 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
556 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 490 | $1 | $2 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
407 | $99 | $256 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
292 | $68 | $182 |
| Cetirizine hydrochloride injection, 0.5 mg An injection containing 0.5 mg of cetirizine hydrochloride, an antihistamine medication. |
280 | $12 | $30 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
188 | $12 | $31 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
162 | $100 | $267 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
143 | $11 | $28 |
| New patient office visit, complex (60-74 min) | 92 | $165 | $447 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
89 | $56 | $149 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
60 | $49 | $132 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
60 | $1 | $2 |
| Same-day hospital admission and discharge, moderate complexity This code covers initial hospital care for a patient admitted and discharged on the same day. It applies when the visit involves moderate medical decision making and lasts at least 70 minutes. |
50 | $123 | $333 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
38 | $135 | $363 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
35 | $90 | $238 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
62.2% high complexity
30.9% medium
6.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$19,940
Total received (2018-2024)
Avg $3,988/year across 5 years
Top 26% in FL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
68
Companies
408
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,974
2023
$3,694
2022
$3,399
2019
$7,408
2018
$1,466
Payments by company (2024)
Takeda Pharmaceuticals U.S.A., Inc.
$315
Merck Sharp & Dohme LLC
$312
Novartis Pharmaceuticals Corporation
$255
PFIZER INC.
$249
AstraZeneca Pharmaceuticals LP
$242
Celgene Corporation
$211
Incyte Corporation
$178
Janssen Biotech, Inc.
$158
Daiichi Sankyo Inc.
$152
GlaxoSmithKline, LLC.
$144
Genentech USA, Inc.
$121
Gilead Sciences, Inc.
$115
Eisai Inc.
$108
E.R. Squibb & Sons, L.L.C.
$108
SOBI, INC
$92
Lilly USA, LLC
$90
Boehringer Ingelheim Pharmaceuticals, Inc.
$81
GENZYME CORPORATION
$75
Pharmacosmos Therapeutics Inc.
$75
Rigel Pharmaceuticals, Inc.
$67
PharmaEssentia USA Corporation
$66
JAZZ PHARMACEUTICALS INC.
$64
Exelixis Inc.
$56
Fennec Pharmaceuticals, Inc.
$55
EMD Serono, Inc.
$54
TAIHO ONCOLOGY, INC.
$49
BeiGene USA, Inc.
$45
Alexion Pharmaceuticals, Inc.
$39
Alnylam Pharmaceuticals Inc.
$38
Novocure Inc.
$35
Myriad Genetic Laboratories, Inc.
$32
ABBVIE INC.
$31
Kite Pharma, Inc.
$29
TerSera Therapeutics LLC
$27
Astellas Pharma US Inc
$23
PUMA BIOTECHNOLOGY, INC.
$23
ADC Therapeutics America, Inc.
$21
SERVIER PHARMACEUTICALS LLC
$21
Acrotech Biopharma Inc.
$20
Mirati Therapeutics, Inc.
$18
Tempus AI, Inc
$17
Sumitomo Pharma America, Inc.
$16
Amneal Pharmaceuticals LLC
$16
Bayer Healthcare Pharmaceuticals Inc.
$15
Aveo Pharmaceuticals, Inc.
$15
Top 3 companies account for 22.2% of 2024 payments
All-time payments by company (2018-2024) ›
Rigel Pharmaceuticals, Inc.
$4,017
Exelixis Inc.
$3,306
Epizyme, Inc.,
$2,917
Janssen Biotech, Inc.
$1,833
Merck Sharp & Dohme LLC
$678
Novartis Pharmaceuticals Corporation
$578
Takeda Pharmaceuticals U.S.A., Inc.
$505
AstraZeneca Pharmaceuticals LP
$467
PFIZER INC.
$412
Celgene Corporation
$360
Daiichi Sankyo Inc.
$340
Incyte Corporation
$331
GlaxoSmithKline, LLC.
$297
Foundation Medicine, Inc.
$289
Genentech USA, Inc.
$273
Gilead Sciences, Inc.
$237
Seagen Inc.
$210
Eisai Inc.
$192
Lilly USA, LLC
$185
PharmaEssentia USA Corporation
$167
Boehringer Ingelheim Pharmaceuticals, Inc.
$158
SOBI, INC
$145
E.R. Squibb & Sons, L.L.C.
$108
BeiGene USA, Inc.
$107
Pharmacosmos Therapeutics Inc.
$104
ARRAY BIOPHARMA INC
$97
EMD Serono, Inc.
$94
GENZYME CORPORATION
$90
Astellas Pharma US Inc
$84
Regeneron Healthcare Solutions, Inc.
$82
Janssen Scientific Affairs, LLC
$70
JAZZ PHARMACEUTICALS INC.
$64
TAIHO ONCOLOGY, INC.
$64
Alexion Pharmaceuticals, Inc.
$61
Mirati Therapeutics, Inc.
$59
Fennec Pharmaceuticals, Inc.
$55
Celltrion USA Inc.
$47
Amneal Pharmaceuticals LLC
$46
SERVIER PHARMACEUTICALS LLC
$44
CTI BioPharma Corp.
$42
TerSera Therapeutics LLC
$42
Agios Pharmaceuticals, Inc.
$40
Puma Biotechnology, Inc.
$38
Alnylam Pharmaceuticals Inc.
$38
Bayer Healthcare Pharmaceuticals Inc.
$36
Novocure Inc.
$35
Coherus Biosciences Inc.
$32
Myriad Genetic Laboratories, Inc.
$32
ABBVIE INC.
$31
Jazz Pharmaceuticals Inc.
$30
Kite Pharma, Inc.
$29
RECORDATI_RARE_DISEASES_INC.
$29
Kyowa Kirin, Inc.
$27
Stemline Therapeutics Inc.
$26
G1 Therapeutics, Inc.
$23
PUMA BIOTECHNOLOGY, INC.
$23
Sun Pharmaceutical Industries Inc.
$22
Genmab U.S., Inc.
$22
ADC Therapeutics America, Inc.
$21
Acrotech Biopharma Inc.
$20
Pharmacyclics LLC, An AbbVie Company
$19
AVEO Pharmaceuticals, Inc.
$18
ImmunoGen, Inc.
$17
Tempus AI, Inc
$17
Sumitomo Pharma America, Inc.
$16
Aveo Pharmaceuticals, Inc.
$15
Telix Pharmaceuticals
$14
Heron Therapeutics, Inc.
$14
Top 3 companies account for 51.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ADVATE · ADYNOVATE · ALUNBRIG · AVASTIN · Alecensa · BAVENCIO · BELEODAQ · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · CABOMETYX · CALQUENCE · CARVYKTI · CINVANTI · COSELA · Cabometyx · Columvi · DARZALEX · DOPTELET · Doptelet · ELREXFIO · ENHERTU · ENJAYMO · ERLEADA · Elahere · Enhertu · Epkinly · Erleada · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE LIQUID CDX · FRUZAQLA · Fabhalta · GILOTRIF · IBRANCE · ILLUCCIX · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Itovebi · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · LIBTAYO · LONSURF · LORBRENA · LUTATHERA · LYNPARZA · Lenvima · MONJUVI · MONOFERRIC · MYRISK · NINLARO · OJJAARA · ONPATTRO · OPDIVO · OPDUALAG · ORGOVYX · Optune · Optune Lua (NovoTTF-200T) · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PYRUKYND · Padcev · Pedmark · Pomalyst · Poteligeo · Quzyttir · REBLOZYL · RYBREVANT · Rezlidhia · SARCLISA · SCEMBLIX · SHINGRIX · SYLVANT · Stivarga · TASIGNA · TECVAYLI · TIVDAK · TUKYSA · Tavalisse · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · VEGZELMA · VENCLEXTA · VERZENIO · VONJO · VONVENDI · Venclexta · Vonjo · WELIREG · XTANDI · Xospata · YONSA · Yescarta · ZEJULA · ZEPZELCA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
17
County median income
$80,633
Nearest hospital to ZIP centroid (approximate)
LAKEWOOD RANCH MEDICAL CENTER
4.7 mi
4.7 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kouri is a mixed practice specialist, with above-average Medicare volume (top 21% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kouri experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Kouri performed 14,250 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Kouri receive payments from pharmaceutical companies?
Yes. Dr. Kouri received a total of $19,940 from 68 companies across 408 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kouri's costs compare to other hematology & oncology specialists in Lakewood Ranch?
Dr. Kouri's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kouri) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Lakewood Ranch
Browse hematology & oncology specialists in Lakewood Ranch ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
Rigel Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Rigel Pharmaceuticals, Inc.
By company
Exelixis Inc. Payments to Doctors
See all physicians who received payments from Exelixis Inc.
By company
Epizyme, Inc., Payments to Doctors
See all physicians who received payments from Epizyme, Inc.,.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology